東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

FindBook

Google Book

Amazon

博客來

Neuroblastoma = discoveries and challenges /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Neuroblastoma/ edited by Shahab Asgharzadeh, Frank Westermann.
其他題名:	discoveries and challenges /
其他作者:	Asgharzadeh, Shahab.
出版者:	Cham :Springer International Publishing : : 2024.,
面頁冊數:	x, 219 p. :ill., digital ;24 cm.
內容註:	Epidemiology, Presentation, and Evaluation -- Pathology of Neuroblastoma -- Genetic Predisposition -- Part I: Evolving Concepts in Neuroblastoma Pathogenesis (Seed):Tumor Genomics: Copy Number Alterations -- Tumor Genomics: Epigenetics -- Tumor Genomics: Genomic Regulation -- Tumor Metabolism -- Part II: Evolving Concepts in Neuroblastoma Immunology and Tumor Microenvironment (Soil): Neuroblastoma Tumor Microenvironment - Adaptive and Innate Immunity -- Neuroblastoma Tumor Microenvironment - Non-Immune Cells and Exosomes -- Part III: Evolving Concepts in Neuroblastoma Precision Medicine: Targeting the Seed and the Soil: Advances in evaluating tumor burden -- Therapeutically Actionable Genetic Aberrations -- Re-engaging the Immune System: Future of Immunotherapy -- Future of Clinical Trials and Application of Precision Medicine -- Summary and the Next 10 Years.
Contained By:	Springer Nature eBook
標題:	Neuroblastoma. -
電子資源:	https://doi.org/10.1007/978-3-031-51292-6
ISBN:	9783031512926

Neuroblastoma = discoveries and challenges /
Neuroblastomadiscoveries and challenges /[electronic resource] :edited by Shahab Asgharzadeh, Frank Westermann. - Cham :Springer International Publishing :2024. - x, 219 p. :ill., digital ;24 cm. - Pediatric oncology,2191-0812. - Pediatric oncology..

Epidemiology, Presentation, and Evaluation -- Pathology of Neuroblastoma -- Genetic Predisposition -- Part I: Evolving Concepts in Neuroblastoma Pathogenesis (Seed):Tumor Genomics: Copy Number Alterations -- Tumor Genomics: Epigenetics -- Tumor Genomics: Genomic Regulation -- Tumor Metabolism -- Part II: Evolving Concepts in Neuroblastoma Immunology and Tumor Microenvironment (Soil): Neuroblastoma Tumor Microenvironment - Adaptive and Innate Immunity -- Neuroblastoma Tumor Microenvironment - Non-Immune Cells and Exosomes -- Part III: Evolving Concepts in Neuroblastoma Precision Medicine: Targeting the Seed and the Soil: Advances in evaluating tumor burden -- Therapeutically Actionable Genetic Aberrations -- Re-engaging the Immune System: Future of Immunotherapy -- Future of Clinical Trials and Application of Precision Medicine -- Summary and the Next 10 Years.

This book provides a state-of-the-art review of the biology, treatment, and other critical aspects of neuroblastoma, reflecting the dramatic advances that have been achieved in understanding and management. Topics are arranged according to the book's dominant themes of the "seed" (tumor genomics, epigenetics, metabolism, and stem cells) and the "soil" (tumor microenvironment, adaptive and innate immunity, and exosomes) and how both of these influences can serve as rich targets for intervention, whether by targeted molecular therapy or immunotherapy. Therapeutic strategies that are currently in use or under consideration for the future are discussed in detail, with the focus on precision medicine. Further individual chapters are devoted to the biology and genetics of relapsed/refractory neuroblastoma and emerging methods of evaluating tumor burden. Finally, in keeping with the, albeit modest, increase in cure rates in high-risk disease, immune and cellular therapies are reviewed. This coverage of what is becoming a not-so-enigmatic tumor will appeal to a broad readership including both experimental oncologists and clinicians who care for patients with neuroblastoma.

ISBN: 9783031512926

Standard No.: 10.1007/978-3-031-51292-6doiSubjects--Topical Terms:

894784
Neuroblastoma.

LC Class. No.: RC280.N4

Dewey Class. No.: 618.929948

Neuroblastoma = discoveries and challenges /
LDR:03079nmm a2200337 a 4500 001 2371756
003 DE-He213
005 20240521063108.0
006 m d
007 cr nn 008maaau
008 241127s2024 sz s 0 eng d
020 $a 9783031512926 $q (electronic bk.)
020 $a 9783031512919 $q (paper)
024 7 $a 10.1007/978-3-031-51292-6 $2 doi
035 $a 978-3-031-51292-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.N4
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 618.929948 $2 23
090 $a RC280.N4 $b N494 2024
245 0 0 $a Neuroblastoma $h [electronic resource] : $b discoveries and challenges / $c edited by Shahab Asgharzadeh, Frank Westermann.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2024.
300 $a x, 219 p. : $b ill., digital ; $c 24 cm.
490 1 $a Pediatric oncology, $x 2191-0812
505 0 $a Epidemiology, Presentation, and Evaluation -- Pathology of Neuroblastoma -- Genetic Predisposition -- Part I: Evolving Concepts in Neuroblastoma Pathogenesis (Seed):Tumor Genomics: Copy Number Alterations -- Tumor Genomics: Epigenetics -- Tumor Genomics: Genomic Regulation -- Tumor Metabolism -- Part II: Evolving Concepts in Neuroblastoma Immunology and Tumor Microenvironment (Soil): Neuroblastoma Tumor Microenvironment - Adaptive and Innate Immunity -- Neuroblastoma Tumor Microenvironment - Non-Immune Cells and Exosomes -- Part III: Evolving Concepts in Neuroblastoma Precision Medicine: Targeting the Seed and the Soil: Advances in evaluating tumor burden -- Therapeutically Actionable Genetic Aberrations -- Re-engaging the Immune System: Future of Immunotherapy -- Future of Clinical Trials and Application of Precision Medicine -- Summary and the Next 10 Years.
520 $a This book provides a state-of-the-art review of the biology, treatment, and other critical aspects of neuroblastoma, reflecting the dramatic advances that have been achieved in understanding and management. Topics are arranged according to the book's dominant themes of the "seed" (tumor genomics, epigenetics, metabolism, and stem cells) and the "soil" (tumor microenvironment, adaptive and innate immunity, and exosomes) and how both of these influences can serve as rich targets for intervention, whether by targeted molecular therapy or immunotherapy. Therapeutic strategies that are currently in use or under consideration for the future are discussed in detail, with the focus on precision medicine. Further individual chapters are devoted to the biology and genetics of relapsed/refractory neuroblastoma and emerging methods of evaluating tumor burden. Finally, in keeping with the, albeit modest, increase in cure rates in high-risk disease, immune and cellular therapies are reviewed. This coverage of what is becoming a not-so-enigmatic tumor will appeal to a broad readership including both experimental oncologists and clinicians who care for patients with neuroblastoma.
650 0 $a Neuroblastoma. $3 894784
650 1 4 $a Oncology. $3 751006
650 2 4 $a Pediatrics. $3 559143
650 2 4 $a Neurology. $3 588698
700 1 $a Asgharzadeh, Shahab. $3 3718004
700 1 $a Westermann, Frank. $3 3718005
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a Pediatric oncology. $3 1568090
856 4 0 $u https://doi.org/10.1007/978-3-031-51292-6
950 $a Medicine (SpringerNature-11650)